what is the most performance mid cap stock between august 2 2012 and december 21 2012

ACADIA Pharmaceuticals (ACAD) had the highest return between August 2, 2012 and December 21, 2012 by a mid-cap US stock, returning 192.9%.

ASSET DATE % RETURN
ACADIA Pharmaceuticals (ACAD)
8/2/2012 - 12/21/2012
192.86%
Vipshop (VIPS)
8/2/2012 - 12/21/2012
192.01%
Sarepta Therapeutics (SRPT)
8/2/2012 - 12/21/2012
170.26%
Sharplink Gaming (SBET)
8/2/2012 - 12/21/2012
131.18%
SkyWest (SKYW)
8/2/2012 - 12/21/2012
96.95%
MGIC Investment (MTG)
8/2/2012 - 12/21/2012
87.18%
Louisiana-Pacific (LPX)
8/2/2012 - 12/21/2012
83.85%
New Oriental Education & Technology (EDU)
8/2/2012 - 12/21/2012
82.69%
Radian (RDN)
8/2/2012 - 12/21/2012
79.61%
Halozyme Therapeutics (HALO)
8/2/2012 - 12/21/2012
79.28%
CVR Energy (CVI)
8/2/2012 - 12/21/2012
74.63%
Eagle Materials (EXP)
8/2/2012 - 12/21/2012
74.39%
Calix (CALX)
8/2/2012 - 12/21/2012
71.79%
Axcelis Technologies (ACLS)
8/2/2012 - 12/21/2012
70.89%
Option Care Health (OPCH)
8/2/2012 - 12/21/2012
67.94%
Melco Resorts & Entertainment (MLCO)
8/2/2012 - 12/21/2012
65.83%
KB Home (KBH)
8/2/2012 - 12/21/2012
65.04%
First Bancorp (FBNC)
8/2/2012 - 12/21/2012
63.91%
Addus HomeCare (ADUS)
8/2/2012 - 12/21/2012
63.7%
Abercrombie & Fitch (ANF)
8/2/2012 - 12/21/2012
63.6%
Riot Blockchain (RIOT)
8/2/2012 - 12/21/2012
62.8%
Civitas Resources (CIVI)
8/2/2012 - 12/21/2012
62.02%
DXC Technology (DXC)
8/2/2012 - 12/21/2012
61.68%
IES (IESC)
8/2/2012 - 12/21/2012
61.25%
Visteon (VC)
8/2/2012 - 12/21/2012
60.65%
Mid-cap stocks are treated as having a market cap between $2B and $10B.